Lonza to buy large-scale biologics Vacaville site from Roche for USD 1.2 billion Ruchika Sharma25 March 2024 10:00 AM ISTBasel: Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced it has signed an agreement...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Crovalimab study Dr. Divya Colin16 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Roche Pharma unveils multiple sclerosis treatment drug Ocrevus in India Ruchika Sharma29 Feb 2024 5:00 PM ISTNew Delhi: Roche Pharma India has launched a drug for the treatment of Multiple Sclerosis (MS), expanding its neurology portfolio to cater...
CDSCO Panel Approves Roche's protocol amendment proposal for anti-cancer drug Atezoluzumab study Dr. Divya Colin25 Feb 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Anti-cancer Drug Giredestrant Dr. Divya Colin24 Feb 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Roche cutting jobs in product development: Report Ruchika Sharma12 Feb 2024 2:06 PM ISTZurich: Roche is cutting 345 jobs, Swiss website Muula reported, as the drugs company responds to lower profit posted for 2023 and a more cautious...
Modify Clinical Study Protocol: CDSCO Panel Tells Roche On Multiple Sclerosis Drug Ocrelizumab Dr. Divya Colin11 Feb 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by drug major Roche to conduct the Phase IV clinical trial for the drug product Ocrelizumab 300 mg...
Conduct India-specific Trial: CDSCO Panel Tells Roche on Satralizumab to Treat neuromyelitisoptica spectrum disorders Dr. Divya Colin8 Feb 2024 6:00 PM ISTNew Delhi: With an aim to establish the safety and efficacy of the Monoclonal Antibody Satralizumab in Indian patients, the Subject Expert Committee...
CDSCO Panel Approves Roche's Protocol Amendment Proposal for Anticancer Drug Giredestrant Dr. Divya Colin4 Feb 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Roche's proposal for marketing Atezolizumab Injection for Subcutaneous route rejected by CDSCO Panel Dr. Divya Colin27 Jan 2024 6:00 PM ISTNew Delhi: Rejecting the drug major Roche's proposal to market the anti-cancer drug Atezolizumab Injection (1875mg/15ml vial) (Tecentriq) for a new...
Roche gets European Commission marketing nod for Tecentriq SC for multiple cancer types Ruchika Sharma20 Jan 2024 11:24 AM ISTBasel: Roche has announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)'s...
Novel antibiotic class promising against invasive infections caused by carbapenem-resistant Acinetobacter: Study Medha Baranwal8 Jan 2024 3:45 AM ISTSwitzerland: A team of researchers from Swiss drugmaker Roche have identified a novel class of antibiotics that target a highly drug-resistant and...
